SRS251 - Necrotizing fasciitis outcomes in diabetic versus non-diabetic patients: a systematic review and meta-analysis
British Journal of Surgery · 27.03.2026 · 113 (Supplement_2)
DOI: 10.1093/bjs/znag018.235 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift British Journal of Surgery, online erschienen am 27.03.2026. Verfasst von Cameron Lynch und 10 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Necrotising fasciitis (NF) is a rapidly progressive, life-threatening infection, a common site being the lower limbs. Diabetes mellitus (DM) is a key risk factor influencing the progression, outcome, and management of NF. Despite its clinical relevance, comparative data on diabetic versus non-diabetic NF outcomes remain limited.
Objectives
Compare mortality, amputation rates, and key outcomes between diabetic and non-diabetic patients with NF.
Methods
A systematic review and meta-analysis were conducted following the PRISMA guidelines. Eligible studies assessed outcomes in diabetic and non-diabetic NF patients. Primary outcome measures were amputation rates, mortality, length of hospital stay, debridement frequency, and microbial growth. Secondary outcomes included the LRINEC score and unplanned reoperations. Pooled analyses were performed using OpenMeta[Analyst] software, reporting odds ratios (OR) and mean differences (MD) with 95% confidence intervals.
Results
Nine studies comprising 1890 patients met the inclusion criteria. Diabetic patients had significantly higher rates of amputation (OR 3.77, 95% c.i.:3.04–4.68, P < 0.001) and polymicrobial infections (OR 2.48, 95% c.i.:1.48–4.16; P < 0.001). Mortality was higher among patients with diabetes after sensitivity analysis (OR 1.60, 95% c.i.:1.09–2.24, P = 0.015). No significant differences were observed in the number of debridements or length of admission. Diabetic patients had higher LRINEC scores (MD 2.02, 95% c.i.:1.33–2.72; P < 0.001).
Conclusions
Diabetic patients with NF experience worse clinical outcomes, including increased risk of amputation rates, mortality, and polymicrobial infections. This meta-analysis underscores the need for prompt, aggressive intervention and risk stratification in DM populations. Further, high-quality prospective studies are required to strengthen the evidence base.
Zitieren
APA
Lynch, C., Mohamed, A., Ong, C., Khan, M., Mohamed, M., Perera, I., Roberts, J., Chai, A., Hussein, H., Zafar, A., & Rahman, S. (2026). SRS251 - Necrotizing fasciitis outcomes in diabetic versus non-diabetic patients: a systematic review and meta-analysis. British Journal of Surgery, 113(Supplement_2). https://doi.org/10.1093/bjs/znag018.235
Vancouver
Lynch C, Mohamed A, Ong C, Khan M, Mohamed M, Perera I, et al. SRS251 - Necrotizing fasciitis outcomes in diabetic versus non-diabetic patients: a systematic review and meta-analysis. British Journal of Surgery. 2026;113(Supplement_2). doi:10.1093/bjs/znag018.235
BibTeX
@article{Lynch2026,
author = {Lynch, Cameron and Mohamed, Abdiqadir and Ong, Chea and Khan, Muneeb and Mohamed, Mohaned and Perera, Isuru and Roberts, Jason and Chai, Aaron and Hussein, Hadeel and Zafar, Abdal and Rahman, Shafiq},
title = {SRS251 - Necrotizing fasciitis outcomes in diabetic versus non-diabetic patients: a systematic review and meta-analysis},
journal = {British Journal of Surgery},
year = {2026},
volume = {113},
number = {Supplement_2},
doi = {10.1093/bjs/znag018.235}
}
EUVIMED